# NSAID Effects on Clinical and Imaging Breast Biomarkers

> **NCT01761877** · PHASE2 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 114 (actual)

## Conditions studied

- Inflammation
- Cancer
- Pain
- Hypertension

## Interventions

- **DRUG:** Sulindac

## Key facts

- **NCT ID:** NCT01761877
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2019-02-07
- **Final completion:** 2019-03-11
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761877, "NSAID Effects on Clinical and Imaging Breast Biomarkers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01761877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*